Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - ACCOUNTS PAYABLE
Accounts Payable ESPR - Esperion Therapeutics, Inc.
31.7 M
LAST VALUE
34.40%
2 YEAR CAGR
-6.71%
5 YEAR CAGR
30.40%
10 YEAR CAGR